Correlation Between Oasmia Pharmaceutical and Collegium Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oasmia Pharmaceutical and Collegium Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oasmia Pharmaceutical and Collegium Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oasmia Pharmaceutical AB and Collegium Pharmaceutical, you can compare the effects of market volatilities on Oasmia Pharmaceutical and Collegium Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oasmia Pharmaceutical with a short position of Collegium Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oasmia Pharmaceutical and Collegium Pharmaceutical.

Diversification Opportunities for Oasmia Pharmaceutical and Collegium Pharmaceutical

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Oasmia and Collegium is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Oasmia Pharmaceutical AB and Collegium Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collegium Pharmaceutical and Oasmia Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oasmia Pharmaceutical AB are associated (or correlated) with Collegium Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collegium Pharmaceutical has no effect on the direction of Oasmia Pharmaceutical i.e., Oasmia Pharmaceutical and Collegium Pharmaceutical go up and down completely randomly.

Pair Corralation between Oasmia Pharmaceutical and Collegium Pharmaceutical

If you would invest  6.00  in Oasmia Pharmaceutical AB on September 4, 2024 and sell it today you would earn a total of  0.00  from holding Oasmia Pharmaceutical AB or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.76%
ValuesDaily Returns

Oasmia Pharmaceutical AB  vs.  Collegium Pharmaceutical

 Performance 
       Timeline  
Oasmia Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oasmia Pharmaceutical AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Oasmia Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Oasmia Pharmaceutical and Collegium Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oasmia Pharmaceutical and Collegium Pharmaceutical

The main advantage of trading using opposite Oasmia Pharmaceutical and Collegium Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oasmia Pharmaceutical position performs unexpectedly, Collegium Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will offset losses from the drop in Collegium Pharmaceutical's long position.
The idea behind Oasmia Pharmaceutical AB and Collegium Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like